Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 250 Carcinoma, Non-Small-Cell Lung 226 Prostatic Neoplasms 118 Neoplasms 106 Multiple Myeloma 91 Neoplasm Metastasis 75 Colorectal Neoplasms 73 Parkinson Disease 4, Autosomal Dominant Lewy Body 69 Lung Neoplasms 67 Ovarian Neoplasms 61 Leukemia, Myeloid, Acute 50 Carcinoma, Hepatocellular 48 Melanoma 47 Carcinoma, Renal Cell 45 Leukemia, Lymphocytic, Chronic, B-Cell 44 Triple Negative Breast Neoplasms 42 Urinary Bladder Neoplasms 41 Stomach Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 41 Recurrence 41 Brain Neoplasms 40 Myasthenia Gravis 37 Small Cell Lung Carcinoma 35 Nasopharyngeal Carcinoma 34 Lymphoma, Follicular 34 Head and Neck Neoplasms 34 Pancreatic Neoplasms 32 Rectal Neoplasms 31 Lymphoma, Large B-Cell, Diffuse 30 Endometrial Neoplasms 29

Interventions

pembrolizumab 1 enfortumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Bladder Cancer × 1 year × Clear all

NCT07346053 2026-01-16

Chrono-EVP

British Columbia Cancer Agency

Phase 3 Not yet recruiting

Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡